Orchid Pharma Bilan de santé
Santé financière contrôle des critères 6/6
Orchid Pharma has a total shareholder equity of ₹11.7B and total debt of ₹1.4B, which brings its debt-to-equity ratio to 11.6%. Its total assets and total liabilities are ₹15.5B and ₹3.8B respectively. Orchid Pharma's EBIT is ₹872.4M making its interest coverage ratio -42.8. It has cash and short-term investments of ₹36.2M.
Informations clés
11.6%
Ratio d'endettement
₹1.35b
Dette
| Ratio de couverture des intérêts | -42.8x |
| Argent liquide | ₹36.16m |
| Fonds propres | ₹11.69b |
| Total du passif | ₹3.84b |
| Total des actifs | ₹15.54b |
Mises à jour récentes de la santé financière
Recent updates
Earnings Tell The Story For Orchid Pharma Limited (NSE:ORCHPHARMA) As Its Stock Soars 26%
Jul 29
We Ran A Stock Scan For Earnings Growth And Orchid Pharma (NSE:ORCHPHARMA) Passed With Ease
Jun 12Orchid Pharma Limited's (NSE:ORCHPHARMA) Intrinsic Value Is Potentially 17% Below Its Share Price
May 08Orchid Pharma Limited's (NSE:ORCHPHARMA) P/S Is Still On The Mark Following 72% Share Price Bounce
Feb 28Does Orchid Pharma (NSE:ORCHPHARMA) Have A Healthy Balance Sheet?
Feb 06Orchid Pharma Limited (NSE:ORCHPHARMA) Looks Just Right With A 33% Price Jump
Dec 18Analyse de la situation financière
Passif à court terme: ORCHPHARMA's short term assets (₹7.9B) exceed its short term liabilities (₹2.6B).
Passif à long terme: ORCHPHARMA's short term assets (₹7.9B) exceed its long term liabilities (₹1.2B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: ORCHPHARMA's net debt to equity ratio (11.3%) is considered satisfactory.
Réduire la dette: ORCHPHARMA had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Couverture de la dette: ORCHPHARMA's debt is well covered by operating cash flow (93.2%).
Couverture des intérêts: ORCHPHARMA earns more interest than it pays, so coverage of interest payments is not a concern.